Zhejiang Medicine Co., Ltd. (SHA:600216)
China · Delayed Price · Currency is CNY 12.33
-0.28 (-2.22%)
Sep 24, 2026, 3:00 PM CST
Zhejiang Medicine Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Zhejiang Medicine stock has a consensus rating of "Buy" and an average price target of ¥17.25. The average 1-year stock price forecast is 39.90% higher than the current stock price, while the lowest is ¥16.00 (+29.76%) and the highest is ¥18.50 (+50.04%).
Price Target: ¥17.25 (+39.90%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Zhejiang Medicine stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Apr '26 | Jun '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Financial Forecast
Revenue This Year
9.02B
from 8.88B
Increased by 1.58%
Revenue Next Year
9.72B
from 9.02B
Increased by 7.74%
EPS This Year
1.14
EPS Next Year
n/a
from 1.14
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.